K033915

Substantially Equivalent

MODIFICATION TO SERAQUEST EB VCA IGG

Applicant: Quest Intl., Inc.
Product code: LSE
Advisory panel: Microbiology
Date received: 2003-12-18
Decision date: 2004-01-16
Decision: Substantially Equivalent
Clearance type: Special
Location: North Miami, FL, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.